We are live on ! Find out more
GCP

GSA Capital Partners Portfolio holdings

AUM $1.61B
1-Year Est. Return 28.28%
This Fund
S&P 500
This Quarter Est. Return
+1.76%
1 Year Est. Return
+28.28%
3 Year Est. Return
+64.67%
5 Year Est. Return
+51.31%
10 Year Est. Return
+329.48%
AUM
$1.41B
AUM Growth
+$140M
Cap. Flow
+$151M
Cap. Flow %
10.75%
Top 10 Hldgs %
8.08%
Holding
2,051
New
446
Increased
504
Reduced
559
Closed
528

Top Sells

Rank Stock Value
1
PFE icon
Pfizer
PFE
+$6.69M
2
C icon
Citigroup
C
+$6.01M
3
TRIP icon
TripAdvisor
TRIP
+$5.94M
4
VPHM
VIROPHARMA INC
VPHM
+$5.33M
5
WELL icon
Welltower
WELL
+$5.33M

Sector Composition

Rank Sector Weight
1 Healthcare 15.61%
2 Technology 11.5%
3 Industrials 10.6%
4 Consumer Discretionary 10.6%
5 Energy 9.3%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
TXT icon
251
Textron
TXT
$15.3B
$1.2M 0.09%
30,505
-16,593
-35% -$620K
CAL icon
252
Caleres
CAL
$479M
$1.2M 0.09%
45,142
+9,207
+26% +$231K
SMG icon
253
ScottsMiracle-Gro
SMG
$3.86B
$1.2M 0.09%
19,553
+3,464
+22% +$206K
AVP
254
DELISTED
Avon Products, Inc.
AVP
$1.2M 0.09%
81,809
+49,270
+151% +$757K
ASH icon
255
Ashland
ASH
$3.31B
$1.2M 0.09%
24,548
+15,695
+177% +$737K
EXPE icon
256
Expedia Group
EXPE
$37.5B
$1.19M 0.08%
+16,450
New +$1.19M
CXW icon
257
CoreCivic
CXW
$2.98B
$1.19M 0.08%
37,980
+23,549
+163% +$776K
XRM
258
DELISTED
Xerium Technologies Inc (new)
XRM
$1.19M 0.08%
74,167
+6,000
+9% +$97.8K
AIG icon
259
American International
AIG
$42.1B
$1.18M 0.08%
23,618
-2,819
-11% -$140K
REGN icon
260
Regeneron Pharmaceuticals
REGN
$78.3B
$1.18M 0.08%
3,927
-12,325
-76% -$3.8M
AVY icon
261
Avery Dennison
AVY
$13.3B
$1.18M 0.08%
23,252
+5,154
+28% +$257K
M icon
262
Macy's
M
$6.89B
$1.17M 0.08%
+19,711
New +$1.1M
ESL
263
DELISTED
Esterline Technologies
ESL
$1.17M 0.08%
10,958
+265
+2% +$27.9K
ICPT
264
DELISTED
Intercept Pharmaceuticals, Inc.
ICPT
$1.17M 0.08%
+3,534
New +$1.19M
OII icon
265
Oceaneering
OII
$5.02B
$1.16M 0.08%
16,205
+3,589
+28% +$257K
OA
266
DELISTED
Orbital ATK, Inc.
OA
$1.16M 0.08%
8,173
-5,287
-39% -$707K
LLTC
267
DELISTED
Linear Technology Corp
LLTC
$1.16M 0.08%
23,859
-1,941
-8% -$89.5K
HSY icon
268
Hershey
HSY
$36B
$1.16M 0.08%
11,103
-5,355
-33% -$548K
CVI icon
269
CVR Energy
CVI
$3.35B
$1.16M 0.08%
27,365
+8,828
+48% +$351K
ENS icon
270
EnerSys
ENS
$7.06B
$1.15M 0.08%
16,651
+2,997
+22% +$210K
QUAD icon
271
Quad
QUAD
$544M
$1.15M 0.08%
49,119
+719
+1% +$17.2K
WNR
272
DELISTED
Western Refining Inc
WNR
$1.15M 0.08%
29,793
-21,986
-42% -$863K
ALJ
273
DELISTED
Alon USA Energy Inc
ALJ
$1.15M 0.08%
76,776
-23,414
-23% -$353K
GT icon
274
Goodyear
GT
$2.07B
$1.14M 0.08%
43,794
-10,800
-20% -$275K
UVV icon
275
Universal Corp
UVV
$1.32B
$1.14M 0.08%
20,450
+6,680
+49% +$366K

Similar funds

GSA Capital Partners's Q1 2014 Portfolio in Review

As of Q1 2014, GSA Capital Partners held 2,051 positions worth $1.41B, up 11% from $1.27B the previous quarter. Its ten largest holdings account for 8.1% of the portfolio.

GSA Capital Partners deployed $151M of net new capital in Q1 2014, opening 446 new positions and adding to 504 existing holdings. Its largest new stake was Alphabet (Google) Class C: 527,450 shares worth $14.6M.

By sector, the portfolio is most concentrated in Healthcare at 16% of assets, up from 13% a quarter earlier, followed by Technology and Industrials.

On the sell side, the largest reduction was Citigroup, an estimated $6.01M trimmed.

  • GSA Capital Partners's largest Q1 2014 buy was Alphabet (Google) Class C: 527,450 shares worth $14.6M.
  • GSA Capital Partners added most to Micron Technology in Q1 2014, an estimated $12.3M increase.
  • GSA Capital Partners's biggest Q1 2014 reduction was Citigroup, cutting an estimated $6.01M.
  • GSA Capital Partners fully exited Pfizer in Q1 2014, selling an estimated $6.69M.
  • GSA Capital Partners's ten largest holdings make up 8.1% of its $1.41B portfolio in Q1 2014.
  • GSA Capital Partners opened 446 new positions and closed 528 in Q1 2014.
  • GSA Capital Partners's portfolio value rose 11% quarter-over-quarter to $1.41B.

Based on GSA Capital Partners's 13F filing for Q1 2014, filed 14 May 2014.